This is the authors' abstract. We don't add key points for this paper.
Genetic profiling revealed that molecular subgroups of patients undergoing allogeneic hematopoietic stem-cell transplantation for MDS may inform prognostic stratification and the selection of conditioning regimen. (Funded by the Edward P. Evans Foundation and others.).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lindsley et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: